Calypsol

Calypsol is a medication containing Ketamine Hydrochloride, used for various medical purposes. It is administered intramuscularly or intravenously and is manufactured by Gedeon Richter Plc. in the EU.

Calypsol, containing Ketamine Hydrochloride, is primarily used for pain management and anesthesia. It is often administered intramuscularly or intravenously to provide relief from severe pain or to induce anesthesia during medical procedures. The medication is also used in certain psychiatric conditions, though specific uses should be discussed with a healthcare provider.

Calypsol may cause a range of effects, including pain relief and sedation. Some users may experience dizziness, nausea, or confusion. The medication works by affecting certain chemicals in the brain, which can lead to a dissociative state, providing relief from pain or inducing anesthesia.

Calypsol should be handled with care and used only as directed by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before using this medication. Pregnant or breastfeeding women should consult their doctor before use.

Calypsol may interact with other medications, including alcohol and certain antidepressants. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol should be avoided while using Calypsol, as it can enhance the sedative effects.